Apotex Inc. vs. Apologistics GmbH – Trademark Opposition TTAB Proceeding 91253151

This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on December 27, 2019 and assigned serial number 91253151 by the TTAB.

Defendant:
Apologistics GmbH represented by JOSEPH F. SCHMIDT of TAFT STETTINIUS & HOLLISTER LLP.
Trademark Information: APODISCOUNTER – US Trademark Serial Number 88227828
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
Apotex Inc. represented by SHERYL DE LUCA of NIXON & VANDERHYE P.C..
Trademark Information: APOPHARMA USA – US Trademark Serial Number 86958426
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
December 27, 2019 – FILED AND FEE
December 27, 2019 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
December 27, 2019 – INSTITUTED
January 15, 2020 – D MOT FOR EXT W/ CONSENT
January 15, 2020 – EXTENSION OF TIME GRANTED
February 28, 2020 – D MOT FOR EXT W/ CONSENT
February 28, 2020 – EXTENSION OF TIME GRANTED
April 30, 2020 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
April 30, 2020 – SUSPENDED
June 23, 2020 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
June 23, 2020 – SUSPENDED
September 02, 2020 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
September 02, 2020 – SUSPENDED
November 02, 2020 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
November 02, 2020 – SUSPENDED
December 28, 2020 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
January 04, 2021 – ANSWER
January 05, 2021 – SUSPENDED
April 05, 2021 – P MOT FOR EXT W/ CONSENT
April 05, 2021 – EXTENSION OF TIME GRANTED
June 10, 2021 – P MOT FOR EXT W/ CONSENT
June 10, 2021 – EXTENSION OF TIME GRANTED
September 15, 2021 – P MOT FOR EXT W/ CONSENT
September 15, 2021 – EXTENSION OF TIME GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.